Are you a Health Professional? Jump over to the doctors only platform. Click Here

MabThera available on the PBS for aggressive lymphoma from 1 July 2003

Print Friendly, PDF & Email

Non Hodgkin’s Lymphoma chemotherapy drug now available on the PBS.

MabThera (rituximab) will be available on the PBS for use in patients with previously untreated, CD20 positive, diffuse large B-cell non-Hodgkin’s lymphoma, in combination with chemotherapy, in patients aged 60 years and over. The maximum quantities are 100mg/10mL vials in packs of two, and 500mg/50mL vials in packs of one, with seven repeat prescriptions. The PBS listing will be effective from 1 July 2003. Advice of this listing will be given in the 1 August 2003 reprint of the Schedule of Pharmaceutical Benefits.

Print Friendly, PDF & Email


Posted On: 17 June, 2003
Modified On: 3 December, 2013


Created by: myVMC